Cereno Scientific has enrolled 9 additional patients in its Expanded Access Program with CS1 providing more long-term safety and efficacy data in rare disease PAH December 27, 2024
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia December 27, 2024
SMT Launches Hydra™ TAVI System in Russia, Offering Advanced Care for Aortic Stenosis Patients December 20, 2024
Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome December 17, 2024
HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial December 17, 2024
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis December 14, 2024
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas December 13, 2024
DanCann Pharma A/S Publishes Q3-2024 Report: Steady Growth in Medicinal Cannabis Prescriptions Signals Promising Future for Patients November 22, 2024
